Thyme Care Names Brad Diephuis Chief

Thyme Care announced a leadership change on July 15, 2026. Thyme Care named president and chief operating officer Brad Diephuis chief executive officer, while co-founder Robin Shah moved to executive chairman to launch new business lines.

What changed

Brad Diephuis was named Chief Executive Officer. Co-founder Robin Shah transitioned to executive chairman to lead Thyme Care’s expansion into new opportunities across drug affordability, clinical trial access, and care alignment.

Leader: Brad Diephuis
Role: Chief Executive Officer
Effective: September 1, 2026
Announcement date: July 15, 2026

Leadership background

Diephuis is a primary care physician with expertise at the intersection of clinical care, healthcare operations, and business strategy, according to the company. He joined Thyme Care in 2022 and served as president and chief operating officer before his promotion. Earlier, he was a senior advisor at the Center for Medicare and Medicaid Innovation (CMMI), where he contributed to the design of ACO REACH and other value-based care models.

The mandate

Thyme Care said Diephuis will lead the company’s continued growth, following his work driving its operations and value-based care model. Diephuis said that as CEO he is committed to making sure every patient, clinician, and health plan the company works with experiences a system that finally moves together.

Why this matters for GTM teams

Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.

Source and methodology

This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.

Thyme Care